Characteristics | BMI < 27 kg/m2 (n = 478) | BMI ≥ 27 kg/m2 (n = 165) | p |
---|---|---|---|
Male, No | 252 (53%) | 80 (48%) | NS |
Age (year-old) | 59 ± 11 | 59 ± 11 | NS |
EAT thickness (mm) | |||
Mean ± SD | 3.0 ± 2.4 | 3.5 ± 2.4 | 0.01 |
Median | 2.8 | 3.0 | 0.01 |
Body Mass Index (kg/m2) | 23.7 ± 2.4 | 29.0 ± 2.1 | < 0.001 |
Waist circumference (cm) | |||
Male | 87.0 ± 8.0 | 97.1 ± 7.5 | < 0.001 |
Female | 84.7 ± 9.1 | 95.0 ± 7.6 | < 0.001 |
Total cholesterol (mg/dl) | 170.6 ± 35.3 | 182.32 ± 39.2 | 0.001 |
LDL cholesterol (mg/dl) | 97.0 ± 30.0 | 104.4 ± 33.7 | 0.025 |
Triglyceride (mg/dl) | 142.1 ± 83.3 | 183.1 ± 109.5 | < 0.001 |
HDL cholesterol (mg/dl) | |||
Male | 44.0 ± 10.7 | 40.3 ± 9.2 | 0.013 |
Female | 48.3 ± 12.7 | 47.1 ± 11.3 | NS |
Fasting glucose (mg/dl) | 115.0 ± 33.9 | 120.0 ± 43.4 | NS |
Hypertension, No | 313 (66%) | 125 (76%) | 0.012 |
Diabetes, No | 295 (62%) | 128 (78%) | < 0.001 |
Smoking, No | 156 (33%) | 41 (25%) | 0.048 |
Metabolic Syndrome, No | 243 (49%) | 133 (81%) | < 0.001 |
Metabolic Score | 2.5 ± 1.3 | 3.3 ± 1.0 | < 0.001 |
Coronary Artery Disease, No | 247 (52%) | 74 (45%) | NS |
Normal & minimal CAD | 230 (48%) | 91 (55%) | NS |
1 vessel | 111 (23%) | 31 (19%) | NS |
2 vessel | 69 (14%) | 24 (15%) | NS |
3 vessel | 65 (14%) | 19 (12%) | NS |
Medication, No | |||
Aspirin | 115 (24%) | 37(22%) | NS |
Beta blockers | 49 (10%) | 19 (12%) | NS |
Calcium channel blockers | 89 (19%) | 33 (20%) | NS |
ACE inhibitors | 23 (5%) | 4 (2%) | NS |
AT II receptor blockers | 58 (12%) | 22 (13%) | NS |
Statins | 46 (10%) | 22 (13%) | NS |
Nitrates | 51 (11%) | 16 (10%) | NS |
Diuretics | 46 (10%) | 18 (11%) | NS |